RedHill Biopharma reported $34.78M in Ordinary Share Capital for its fiscal quarter ending in June of 2024.


Ordinary Share Capital Change Date
Clal Biotechnology ILS 1.61M 0 Dec/2022
Compugen USD 93.54M 93.29M Jun/2025
Cronos Group USD 383.81M 285.23M Jun/2025
RedHill Biopharma USD 34.78M 13.34M Jun/2024